Opportunities for intervention in HSDD

Journal of Family Practice

Volumn 58, Issue 7 SUPPL., 2009, Pages

  Simon, James A ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOACTIVE SEXUAL DESIRE DISORDER; MEDICAL DECISION MAKING; MEDICAL PRACTICE; REVIEW; SEXUAL DYSFUNCTION; TREATMENT INDICATION;

ADMINISTRATION, CUTANEOUS; ADULT; COMBINED MODALITY THERAPY; ESTROGEN REPLACEMENT THERAPY; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; LIBIDO; MIDDLE AGED; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE; TREATMENT OUTCOME;

EID: 67650484190     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition, text revision. Washington, DC: American Psychiatric Press; 2000.
2. Lindau ST, Schumm LP, Laumann EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357:762-774. (Pubitemid 47295643)
3. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537-544. (Pubitemid 29081307)
4. Marwick C. Survey says patients expect little physician help on sex. JAMA. 1999;291:2173-2174. (Pubitemid 29275691)
5. Harsh V, McGarvey EL, Clayton AH. Physician attitudes regarding hypoactive sexual desire disorder in a primary care clinic: a pilot study. J Sex Med. 2008;5:640-645. (Pubitemid 351337891)
6. Nusbaum MR, Gamble G, Skinner B, et al. The high prevalence of sexual concerns among women seeking routine gynecological care. J Fam Pracr. 2000;49:229-232. (Pubitemid 30461290)
7. Kingsberg S. Just ask! Talking to patients about sexual function. Sexuality Reprod Menopause. 2004;2:199-203. (Pubitemid 40260284)
8. Basson R. Sexuality and sexual disorders. Clinical Updates in Women's Health Care. 2003;11:1-94.
9. Bachmann G. Female sexuality and sexual dysfunction: are we stuck on the learning curve? J Sex Med. 2006;3:639-645.
10. Brotto LA. Psychologic-based desire and arousal disorders: treatment strategies and outcome results. In: Goldstein I, Meston CM, Davis SR, et al, eds. Women's Sexual Function and Dysfunction: Study, Diagnosis, and Treatment. New York: Taylor & Francis; 2006.
11. Meston CM, Bradford A. Sexual dysfunctions in women. Annu Rev Clin Psychol. 2007;3:233-256.
12. McCabe M. Evaluation of a cognitive behavioral program for people with sexual dysfunction. J Sex Marital Ther. 2001;27:259-271. (Pubitemid 32374398)
13. Carey JC. Disorders of sexual desire and arousal. Obstet Gynecol Clin N Am. 2006;33:549-564.
14. Segraves RT. Management of hypoactive sexual desire disorder. Adv Psychosom Med. 2008;29:23-32.
15. Berman JR, Berman LA, Toler SM, et al. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo-controlled study. J Urol. 2003;170:2333-2338. (Pubitemid 37413990)
16. Nurnberg HG, Hensley PL, Heiman JR, et al. Sildenafil treatment of women with antidepressant-associated sexual dysfunction. JAMA. 2008;300:395-404.
17. Segraves RT, Clayton A, Croft H, et al. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol. 2004;24:339-342. (Pubitemid 38658043)
18. Segraves R, Woodard T. Female hypoactive sexual desire disorder: history and current status. J Sex Med. 2006;3:408-418.
19. Goldfischer E, Pyke R. Miki J. The Rose study: placebo-controlled randomized withdrawal trial of flibanserin for hypoactive sexual desire disorder in premenopausal women. Sexologies. 2008;17(suppl 1):S121.
20. Diamond L. Co-administration of low dose intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response. Urology. 2005;65:755-759. (Pubitemid 40523013)
21. Safarinejad MR. Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose-randomized study. J Sex Med. 2008;5:887-897.
22. Shadiack AM, Sharma SD, Earle DC, et al. Melanocortins in the treatment of male and female sexual dysfunction. Curr Top Med Chem. 2007;7:1137-1144. (Pubitemid 47044744)
23. PL-6983 is the new bremelanotide. Bremelanotide Bull. 2008; May 20:1-10. http://www.bremolanotide.com/bremelanotide-bulletin/index.php. Accessed April 2, 2009.
24. Palatin Technologies, Inc. Bremelanotide for organ protection and related indications. http://www.palatin.com/pdfs/bremelanotide.pdf. Accessed March 18, 2009.
25. Simon JA. The role of testosterone in the treatment of hypoactive sexual desire disorder in postmenopausal women. Menopause Manage. 2005;Nov/Dec:6-11, 32.
26. Abdullah RT, Simon JA. Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder. Int J Impotence Res. 2007;19:458-463. (Pubitemid 47367524)
27. Hubayter Z, Simon JA. Testosterone therapy for sexual dysfunction in postmenopausal women. Climacteric. 2008;11:181-191.
28. Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005;90:5226-5233. (Pubitemid 41262278)
29. Davis SR, Moreau M, Kroll R, et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med. 2008;359:2005-2017.
30. Goldstat R, Briganti E, Tran J, et al. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause. 2003;10:390-398.
31. Simon J. Testosterone gel (LibiGel™) significantly improves sexual function in surgically menopausal women in phase II study. Presented at: Annual Meeting of the International Society for the Study of Women's Sexual Health. Atlanta, GA; October 30, 2004.
32. Simon JA. Efficacy and safety of testosterone therapy. Presented at: Annual Meeting of the International Society for the Study of Women's Sexual Health. San Diego, CA; February 21, 2008.
33. Jayne C. An evidence-based review of herbal therapies for the treatment of female sexual dysfunction. 2005. http://www.femalesexualdysfunction-online. org. Accessed March 10, 2009.
34. Kang BJ, Lee SJ, Kim MD, et al. A placebo-controlled, double-blind trial of ginkgo biloba for antidepressant-induced sexual dysfunction. Hum Psychopharmacol. 2002;17:279-284. (Pubitemid 34928306)
35. Meston CM, Worcel M. The effects of yohimbine plus L-arginine glutamate on sexual arousal in postmenopausal women with sexual arousal disorder. Arch Sex Behav. 2002;31323-31332 (Pubitemid 38471091)
36. Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 1999;341:1013-1020. (Pubitemid 29451796)
37. Lovas K, Gebre-Medhin G, Trovik TS, et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab. 2003;88:1112-1128.
38. Barnhart KT, Freeman E, Grisso JA, et al. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab. 999;84:3896-3902.
39. Morales AJ, Haubrich RH, Hwang JY, et al. The effect of six months' treatment with 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age advanced men and women. Clin Endocrinol. 1998;49:421-423. (Pubitemid 28475333)
40. Ferguson DRM, Steidle CP, Singh GS, et al. Randomized, placebo-controlled, double-blind, cross-over design trial of the efficacy and safety of Zestra for Women in women with and without female sexual arousal disorder. J Sex Marital Ther. 2003;29(suppl 1):33-44. (Pubitemid 36070978)
41. Ito TY, Trant AS, Polan ML. A double-blind placebo-controlled study of ArginMax, a nutritional supplement for enhancement of female sexual function. J Sex Martial Ther. 2001;27:541-549. (Pubitemid 32802789)
42. Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med. 1997;127:61-69. (Pubitemid 27283905)